COVID-19 Sensitive EM Publishing Process
Step and Responsible Party
|1 – Authoring Component||Submits COVID-19 Sensitive EM to the PolicyNet Publications Staff. |
IMPORTANT: The authoring component will advise what concerns, if any, they have with the public release of information contained in the COVID-19 Sensitive EM. The author will provide any concerns with public disclosure on the Associate Commissioner (AC) signoff sheet.
|2 – PolicyNet Publications Staff||Reviews content, formatting, and signoffs, as appropriate. Analyst sends draft COVID-19 Sensitive EM to management for approval to publish to PolicyNet. |
|3 – PolicyNet Publications Management||Forwards COVID-19 Sensitive EM to the Assistant Deputy Commissioner for Retirement and Disability Policy (DCRDP) for approval. Once approved by DCRDP, send COVID-19 Sensitive EM to PolicyNet Postings for publication to PolicyNet.|
|4 – PolicyNet Publications Staff||Publishes COVID-19 Sensitive EM to PolicyNet.||PN Postings will place a pending Office of General Counsel (OGC)/Office of Privacy and Disclosure (OPD) date on the COVID-19 Sensitive EM Contact Sheet|
|4a – PolicyNet Publications Management||Sends COVID-19 Sensitive EM to OPD by email for review. |
IMPORTANT: Within the email to OPD, include any concerns the author provided about the public release of information contained in the COVID-19 Sensitive EM.
|Input 5 business day follow-up with flag labeled: “PENDING in OPD” |
|5 – OGC/OPD||Conducts review to determine applicable Freedom of Information Act (FOIA) Exemptions. |
Sends version (PDF) with applicable FOIA withholdings to PolicyNet Publications Staff.
|As needed, OPD will coordinate review with the Office of General Law. The length and complexity of the COVID-19 Sensitive EM may affect review time. |
OPD may also reach out to ODEPPIN or the authoring component/subject matter expert for questions, as necessary, which may also affect review time.
|6- PolicyNet Publications Management||1. Publish on SSA.gov (Public Policy site) the public version of the COVID-19 Sensitive EM.|
2. Cross-reference the public version of the COVID-19 Sensitive EM on PolicyNet (Internal Policy site).